Skip to main content

Medical Oncology

Ausgabe 6/2016

Inhalt (6 Artikel)

Editorial

“No patient left behind”: an alternative to “the War on Cancer” metaphor

Bryan T. Oronsky, Corey A. Carter, Arnold L. Oronsky, Michael E. Salacz, Tony Reid

Original Paper

Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer

Asta Bye, Nima Wesseltoft-Rao, Per Ole Iversen, Grete Skjegstad, Kirsten B. Holven, Stine Ulven, Marianne J. Hjermstad

Original Paper

Rap2B promotes cell proliferation, migration and invasion in prostate cancer

Jiehui Di, Huan Cao, Juangjuan Tang, Zheng Lu, Keyu Gao, Zhesi Zhu, Junnian Zheng

Open Access Original Paper

ERAS protocol in laparoscopic surgery for colonic versus rectal carcinoma: are there differences in short-term outcomes?

Michał Pędziwiatr, Magdalena Pisarska, Michał Kisielewski, Piotr Major, Anna Mydlowska, Mateusz Rubinkiewicz, Marek Winiarski, Andrzej Budzyński

Original Paper

Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib

Hiroyuki Kobayashi, Kazuhiro Sato, Takenori Niioka, Masahide Takeda, Yuji Okuda, Mariko Asano, Hiroshi Ito, Masatomo Miura

Original Paper

Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?

Mahmoud Abbas, Sandra Steffens, Maria Bellut, Jan U. Becker, Anika Großhennig, Hendrik Eggers, Gerd Wegener, Markus A. Kuczyk, Hans H. Kreipe, Viktor Grünwald, Andres J. Schrader, Philipp Ivanyi

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.